CEO pay, fiscal year to Dec 31, 2025
Dr. Leighton was paid $16.0M as reported, $12.4M at the share price
CEO pay, as reported
$16.0M
salary, bonus and awards at grant value
CEO pay, actually paid
$12.4M
awards valued at the share price
$100 in the shares became
$83
peer group: $258
CEO pay, 5 years
$68.3M
up 34%
while net income fell 31%
Pay versus performance
Pay against results, year by year
| Fiscal year to | CEO | CEO pay (reported) | CEO pay (actually paid) | Other executives, average | $100 became | Peer group | Net income | Revenue (adjusted for foreign exchange) |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | Dr. Leighton | $16.0M | $12.4M | $6.2M | $83 | $258 | $452.0M | $4.1B |
| Dec 31, 2024 | - | $15.1M | $1.7M | $5.5M | $91 | $208 | $505.0M | $4.0B |
| Dec 31, 2023 | - | $13.4M | $26.2M | $5.1M | $113 | $152 | $548.0M | $3.8B |
| Dec 31, 2022 | - | $12.0M | $3.5M | $4.4M | $80 | $97 | $524.0M | $3.6B |
| Dec 31, 2021 | - | $12.0M | $15.7M | $4.3M | $111 | $135 | $652.0M | $3.3B |
Pay versus performance table of the proxy statement (DEF 14A) filed Mar 31, 2026, as tagged by the company in XBRL. Open the proxy ↗